Helsinn Birex Pharmaceuticals
Lugano
About Helsinn Birex Pharmaceuticals
At Helsinn, their vision is to help people with cancer get the most out of every day. They are committed to making everything they do ’from the products they choose to license to the exacting standards we apply as a pharmaceutical manufacturer’ count towards the best supportive care for cancer patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $7.0M
- Last round: Series Unknown (May 2018)
- Website: helsinn.com
- Phone: 353 1 822 5404
Industries & Categories
Health Care, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/helsinn-birex-pharmaceuticals-83287 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.